Novelion Therapeutics Announces Presentation of Metreleptin Data at American Diabetes Association
GlobeNewswire (press release) The study, titled “Rate of Diabetes Remission in Generalized Lipodystrophy Patients Treated with Metreleptin,” was a post-hoc analysis of a prospective, open-label study of 53 patients conducted at the National Institutes of Health. The study assessed ... |
Social Plugin